Northern Trust Corp Gelesis Holdings, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.11 - $0.52 $384 - $1,816	3,494 Added 2.89%	124,418 $19,000
Q4 2022 Feb 13, 2023	BUY	$0.22 - $0.51 $2,343 - $5,433	10,653 Added 9.66%	120,924 $35,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $1,414 - $23,691	17,680 Added 19.09%	110,271 $119,000
Q2 2022 Aug 12, 2022	BUY	N/A	52,951 Added 133.58%	92,591 $143,000
Q1 2022 May 13, 2022	BUY	N/A	39,640 New	39,640 $180,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.